Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The New England Journal of Medicine
|
March 18, 2006
Response to expression of concern regarding VIGOR study
Alise Reicin, Deborah Shapiro
Adapted Physical Activity Quarterly : APAQ
|
February 29, 2024
The Palgrave Handbook of Disability Sport in Europe: Policies, Structures, and Participation
Wellington De Luna-Vazquez, Deborah Shapiro
Statistics in Medicine
|
May 4, 2004
The role of the unblinded sponsor statistician
Steven Snapinn, Thomas Cook, Deborah Shapiro, et al.
Pediatric Rheumatology Online Journal
|
May 15, 2009
Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
Kirk Sperber, Christine Hom, Chun Peng Chao, et al.
The American Journal of Cardiology
|
January 17, 2002
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone)
Alise S Reicin, Deborah Shapiro, Rhoda S Sperling, et al.
Comprehensive Therapy
|
January 15, 2011
Gout and hyperuricemia
Chandra S Chilappa, Wilbert S Aronow, Deborah Shapiro, et al.
Gastroenterology
|
October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis
Loren Laine, Claire Bombardier, Christopher J Hawkey, et al.
Cardiovascular Diabetology
|
January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Samuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal women
Diane Plotkin, Sam Miller, Steven Nakajima, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes
Mary Jane Geiger, Cyrus Mehta, J Rick Turner, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The New England Journal of Medicine
|
March 18, 2006
Response to expression of concern regarding VIGOR study
Alise Reicin, Deborah Shapiro
Adapted Physical Activity Quarterly : APAQ
|
February 29, 2024
The Palgrave Handbook of Disability Sport in Europe: Policies, Structures, and Participation
Wellington De Luna-Vazquez, Deborah Shapiro
Statistics in Medicine
|
May 4, 2004
The role of the unblinded sponsor statistician
Steven Snapinn, Thomas Cook, Deborah Shapiro, et al.
Pediatric Rheumatology Online Journal
|
May 15, 2009
Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
Kirk Sperber, Christine Hom, Chun Peng Chao, et al.
The American Journal of Cardiology
|
January 17, 2002
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone)
Alise S Reicin, Deborah Shapiro, Rhoda S Sperling, et al.
Comprehensive Therapy
|
January 15, 2011
Gout and hyperuricemia
Chandra S Chilappa, Wilbert S Aronow, Deborah Shapiro, et al.
Gastroenterology
|
October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis
Loren Laine, Claire Bombardier, Christopher J Hawkey, et al.
Cardiovascular Diabetology
|
January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Samuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal women
Diane Plotkin, Sam Miller, Steven Nakajima, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes
Mary Jane Geiger, Cyrus Mehta, J Rick Turner, et al.
Page
of 1